Global Automated Breast Ultrasound System Industry to exceed USD 2 billion by 2024 - PowerPoint PPT Presentation

About This Presentation

Global Automated Breast Ultrasound System Industry to exceed USD 2 billion by 2024


Get more details @ Automated Breast Ultrasound System Market share dominated by key industry players; includes GE Healthcare, Siemens, Hitachi, SonoCine, and Philips Healthcare. – PowerPoint PPT presentation

Number of Views:46


Transcript and Presenter's Notes

Title: Global Automated Breast Ultrasound System Industry to exceed USD 2 billion by 2024

Automated Breast Ultrasound System Market to grow
at 21 CAGR from 2016 to 2024
Fuel Cell Market size worth 25.5bn by 2024
Key Insights of ABUS Market
  • ABUS Market is driven by rising demand for
    effective breast screening techniques due to high
    occurrence of breast cancer in patients to push
  • According to Global Market Insights, Inc.,
    Automated Breast Ultrasound System (ABUS) Market
    size is forecast to hit USD 2 billion by 2024.
    Increase in the rate of detection of breast
    cancer in the asymptomatic women patients having
    dense breast tissues is expected to support the
    industry trends over the next few years.
  • As per World Cancer Research Fund International,
    incidence of breast cancer in women was projected
    to be higher than 25 as compared to other cancer
    types, with over 1.6 million new breast cancer
    cases detected in 2012.
  • Furthermore, growing awareness about breast
    cancer among the women along with favorable
    legislations encouraging breast screening will
    boost ABUS industry revenue over the years to
  • Automated breast volume scanner (ABVS) and
    Automated breast ultrasound system (ABUS) are the
    major breast screening systems.

  • ABVS industry is forecast to surpass USD 950
    million by 2024. Improvement in the
    reproducibility of pictures, high resolution
    imaging, and reduction in scanning time are the
    key features of the ABVS system predicted to
    drive the revenue.
  • ABUS Industry, which dominated the overall
    revenue in 2015, is anticipated to witness a
    significant surge over the coming timeframe.
    Rapid turnaround time, accurate diagnostic
    outcomes, and cost-efficiency are few of the key
    growth drivers of the industry.
  • Automated breast ultrasound systems find
    extensive applications across hospitals and
    diagnostic imaging centers. Hospitals, which
    accounted over 60 of the market share, is
    forecast to record a CAGR of 21.2 over
  • China ABUS industry value is anticipated to hit
    USD 1 billion by 2024, driven by the high
    occurrence of breast cancer along with the
    growing awareness about early breast cancer
  • U.S. ABUS market share, which dominated the
    regional landscape in 2015, is projected to
    observe a remarkable growth over the coming
    years. Increase in the number of breast cancer
    cases and heavy government funding for research
    activities related to breast cancer research will
    drive the revenue.

U.S. Automated Breast Ultrasound System Market
size, by Product, 2012 - 2024 (USD Mn)


Browse Full Market Research Report Automated
Breast Ultrasound System Market _at_
http// Request for a Sample
of this Research report _at_ https//www.fractovia.or
Table of Contents
Chapter 1. Methodology and Scope 1.1.
Research Methodology 1.1.1. Initial data
exploration 1.1.2. Statistical model and
forecast 1.1.3. Industry insights and
validation 1.2. List of Data Sources 1.2.1.
Primary Sources 1.2.2. Secondary
Sources Chapter 2. Executive Summary 2.1.
Automated Breast Ultrasound System Market 3600
synopsis, 2012 - 2024 2.1.1. Business
trends 2.1.2. Regional trends 2.1.3.
Technology trends Chapter 3. Automated
Breast Ultrasound System Industry Insights 3.1.
Industry segmentation 3.2. Industry size,
forecast, and growth expectation, 2012 - 2024
3.3. Automated breast ultrasound system
market dynamics 3.3.1. Growth
drivers Increasing prevalence of
breast cancer Technological
advancements in the field Rising
awareness regarding breast cancer and favorable
government initiatives 3.3.2. Market
restraints Inadequate reimbursement
policies Lack of technical expertise
3.4. Key market growth opportunities 3.5
Regulatory Landscape 3.5.1 U.S. 3.5.2
Europe 3.5.3 China 3.6 Product
Landscape 3.6.1 FDA approved products 3.6.2
Pipeline products 3.7. Porters
analysis 3.8. PESTEL analysis 3.9.
Competitive benchmarking, 2015 3.9.1 Strategy
Stay In Touch Website https//
Social Media
Write a Comment
User Comments (0)